<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00440739</url>
  </required_header>
  <id_info>
    <org_study_id>SiEc 161/2548</org_study_id>
    <nct_id>NCT00440739</nct_id>
  </id_info>
  <brief_title>Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)</brief_title>
  <official_title>Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy: A Factorial Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether etoricoxib, flavoxate, both are effective&#xD;
      in the treatment postoperative pain after TURP.&#xD;
&#xD;
      The research hypothesis:&#xD;
&#xD;
      There is a difference in postoperative morphine consumption in the first 24 hours after&#xD;
      transurethral prostatectomy between patients who received etoricoxib or flavoxate or both and&#xD;
      placebo.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative pain is still a significant problem for surgical patients. Conventional use of&#xD;
      narcotics for postoperative pain relief is not without serious side effects such as&#xD;
      respiratory depression and sedation.There are other alternatives for postoperative analgesia&#xD;
      as NSAIDs especially COX2-inhibitors. For some specific operation such as TURP which Foley's&#xD;
      catheter needed to be retained for a few days,urinary anti spasmodics may help the patients&#xD;
      to be more comfortable.&#xD;
&#xD;
      Comparison(s): There is a difference in postoperative morphine consumption in the first 24&#xD;
      hours after transurethral prostatectomy between patients who received etoricoxib or flavoxate&#xD;
      or both and placebo.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The patients' total amount of morphine requirement in the first 24 hour.</measure>
    <time_frame>24 hour</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1=placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2= etoricoxib</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3=falvoxate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>etoricoxib and flavoxate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoricoxib</intervention_name>
    <description>etoricoxib 120 mg</description>
    <arm_group_label>2</arm_group_label>
    <other_name>arcoxia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>flavoxate</intervention_name>
    <description>flavoxate 200 mg 3 times</description>
    <arm_group_label>3</arm_group_label>
    <other_name>urispas</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoricoxib, flavoxate</intervention_name>
    <description>etoricoxib 120 mg once and flavoxate 200 mg 3 times</description>
    <arm_group_label>4</arm_group_label>
    <other_name>arcoxia</other_name>
    <other_name>urispas</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo once and placebo 3 times</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male patient ASA physical status I-III.&#xD;
&#xD;
          2. Scheduled for an elective TURP.&#xD;
&#xD;
          3. Body weight &gt; or = 50 kg&#xD;
&#xD;
          4. Can operate a patient-controlled analgesia (PCA) device.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of asthma, acute rhinitis, nasal polyps, angioneurotic edema or urticaria&#xD;
             following the administration of aspirin or other NSAIDs.&#xD;
&#xD;
          2. Known hypersensitivity to morphine.&#xD;
&#xD;
          3. History of hepatic dysfunction.&#xD;
&#xD;
          4. Creatinine clearance &lt; 30ml/min.&#xD;
&#xD;
          5. History of bleeding tendency.&#xD;
&#xD;
          6. History of gastrointestinal bleeding or active peptic ulcer.&#xD;
&#xD;
          7. Known case of inflammatory bowel disease.&#xD;
&#xD;
          8. Patient with severe heart failure.&#xD;
&#xD;
          9. History of coronary artery disease or cerebrovascular disease.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sirilak Suksompong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2007</verification_date>
  <study_first_submitted>February 2, 2006</study_first_submitted>
  <study_first_submitted_qc>February 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2007</study_first_posted>
  <last_update_submitted>February 4, 2009</last_update_submitted>
  <last_update_submitted_qc>February 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ethic committee Mahidol University</name_title>
    <organization>Mahidol University</organization>
  </responsible_party>
  <keyword>postoperative pain, etoticoxib, etoricoxib</keyword>
  <keyword>Pain relief after transurethral resection of prostate.</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Etoricoxib</mesh_term>
    <mesh_term>Flavoxate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

